SlideShare a Scribd company logo
1 | P a g e
IInniittiiaattiinnggCCoovveerraaggee
Vaibhav Global Ltd. (VGL)
QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144
4
Recommendation HOLD Outlook continues to remain positive
As expected, the company reported sales growth of 20.3% yoy to Rs 301 cr, on
account of sluggish TV Sales, which posted volume growth of 3.3% (vs 24.5% in
Q4FY14 and 25.1% in Q1FY14), was down because of (1) Change in call center
from in-house to third party (2) Build up of inventory at studio – as indicated by
the company before the start of the quarter (3) Installation of new software.
On account of above factors, we believe Q1 is a temporary blip and expect the
growth to be normalized from Q3 onwards (Q2 is seasonally weak quarter for
the company). Web sales volume grew by 36% and we expect to remain strong
for the rest for the year. EBITDA has declined 24.5% yoy to Rs 26.3 cr.
Consequently margins have also come down to 8.7% as against 13.9% in
Q1FY14.
We continue to like asset light business model of VGL which can generate high
ROCE and free cash. VGL has stabilized itself as a retailer of discount fashion
accessories through TV channel in US and UK market with access to over 100
million households and also trying to monetize its TV channel through
development of web sales. We expect VGL to report an EPS of Rs. 45.2 and Rs.
58.8 in FY15E and FY16E respectively. At CMP of Rs. 850, VGL is trading at a PE
of 18.8x FY15E and 14.5x FY16E. On 16x FY16E earnings our target price comes
to Rs. 925 per share. We maintain HOLD rating.
 Increase in average selling price: VGL reported increase in average selling
price both in TV sales and Web sales segment. This is testament to
company’s growing acceptability in the targeted markets. Web sales average
selling price is $14 as compared to $11 in Q1FY14 whereas TV sales average
price is $25 as compared to $ 24 in Q1FY14.
 Web Sales supported the sales growth: Web sales grew by 79% to Rs 59 cr,
compensated the decline in TV sales were impacted on account of one-time
factors. We expect the company to continue the growth momentum for
Web sales and believe TV sales to come back on track from Q3 onwards.
 EBITDA declined: VGL reported an EBITDA margin of 8.7% down from 13.9%
in Q1FY14 due to additional one-time cost the company has incurred during
the quarter. The fact can be validated by difference between the gross
margins which 68.8% in Q1FY15 vs 70.5% in QFY14. We expect VGL to report
12.4% margins for FY15E as against 11.0% in FY14.
 PAT down: PAT is partially down by lower EBITDA and partially by higher tax.
PAT for Q1FY15 is Rs 21.8 cr, down 45.5% yoy. As VGL’s accumulated losses
got over, it’s both units – US and India have started paying tax (India under
MAT and US full tax) and expected to have average tax rate of 25% for FY15.
 Strong Cash Flow: The Company is having strong cash flow and utilizing the
same to repay its debt. It has repaid Rs 29 cr in Q1FY15 and likely to debt
free by FY15.
CMP Rs. 850
Target Price Rs. 925
Sector Retail
Stock Details
BSE Code 532156
NSE Code VAIBHAVGBL
Bloomberg Code VGM IN
Market Cap (Rs cr) 2,767
Free Float (%) 62.9%
52- wk HI/Lo (Rs) 910/160
Avg. volume BSE (Quarterly) 15,039
Face Value (Rs) 10.0
Dividend (FY 14) NIL
Shares o/s (Crs) 3.2
Relative Performance 1Mth 3Mth 1Yr
Vaibhav 6.9% 16.6% 422.9%
Sensex 2.7% 16.4% 34.8%
Shareholding Pattern 30
th
June 14
Foreign Promoter
Indian Promoters Holding
40.78
Institutional (Incl. FII) 15.87
Corporate Bodies 4.8
Public & others 38.55
Runjhun Jain – Senior Research Analyst
+91-22 3926 8177
runjhun.jain@nirmalbang.com
Year
Net Sales
(Rs. in cr) Growth % EBIDTA EBIDTAM (%) APAT PATM (%)
AEPS
(Rs.) P/E (x)
EV/Sales
(x) ROE
FY13A 892.9 38.1% 63.9 7.2% 57.1 6.4% 17.8 48.1 3.0 26.7%
FY14A 1298.3 45.4% 142.2 11.0% 132.8 10.2% 41.3 20.6 2.1 67.6%
FY15E 1619.8 24.8% 200.4 12.4% 145.6 9.0% 45.2 18.8 1.6 47.6%
FY16E 1996.5 23.3% 255.0 12.8% 189.2 9.5% 58.8 14.5 1.3 40.0%
2 | P a g e
IInniittiiaattiinnggCCoovveerraaggee
Vaibhav Global Ltd. (VGL)
QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144
Q1FY15 Consolidated Result Analysis
Rs. in crore
Particulars Q1FY15 Q1FY14 YoY% Q4FY14 QoQ%
Net Sales 301.4 250.6 20.3% 359.6 -16.2%
Other Operating Income 1.8 2.5 -26.9% 4.2 -57.1%
Total Income 303.2 253.1 19.8% 363.9 -16.7%
Increase / Decrease in Stock -9.6 -16.3 28.0
Consumption of RM 51.8 53.1 -2.4% 56.9 -8.9%
Purchase of traded goods 51.8 37.2 39.3% 48.7 6.3%
Total Raw-material Cost 94.0 73.9 27.2% 133.5 -29.6%
Gross Profit 207.4 176.7 17.4% 226.1 -8.3%
Employees Cost 46.4 41.4 12.0% 59.5 -22.0%
Other Expenditure 136.5 102.9 32.6% 137.0 -0.4%
Total Expenditure 276.8 218.2 26.9% 330.0 -16.1%
EBITDA 26.3 34.9 -24.5% 33.9 -22.2%
Interest 2.5 3.5 -28.3% 3.0 -18.4%
Other Income 0.0 0.0 0.0
EBDT 23.9 31.4 -24.1% 30.8 -22.6%
Depreciation 2.0 1.4 36.5% 2.5 -21.8%
Exchange Gain/Loss 3.5 10.8 1.5
Exceptional Items 0.0 0.0 0.0
PBT 25.4 40.8 -37.7% 29.8 -14.8%
Tax 3.6 0.7 -6.9
Reported PAT 21.8 40.0 -45.5% 36.8 -40.6%
EPS (Unit Curr.) 6.8 12.5 11.4
Equity 32.2 32.1 32.2
Face Value 10 10 10
BPS BPS
Gross Margin (%) 68.8% 70.5% 120 62.9% -510
EBITDA (%) 8.7% 13.9% 740 9.4% -360
EBDT (%) 7.9% 12.5% 810 8.6% -330
PAT (%) 7.2% 16.0% 7150 10.2% 160
3 | P a g e
IInniittiiaattiinnggCCoovveerraaggee
Vaibhav Global Ltd. (VGL)
QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144
Segmental Breakup:
Source: Company & Nirmal Bang Research
4 | P a g e
IInniittiiaattiinnggCCoovveerraaggee
Vaibhav Global Ltd. (VGL)
QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144
Consolidated Financials
Profitability (Rs. In Cr) FY13 FY14E FY15E FY16E Balance Sheet FY13 FY14E FY15E FY16E
Revenues - Net 892.9 1298.3 1619.8 1996.5 Issued Share Capital 32.1 32.2 32.2 32.2
% change 38.1% 45.4% 24.8% 23.3% Redeemable Pref Share 44.0 0.0 0.0 0.0
EBITDA 63.9 142.2 200.4 255.0 Total Shares 76.1 32.2 32.2 32.2
% change -13.6% 122.6% 40.9% 27.2% Reserves & Surplus 83.1 200.8 346.3 535.5
Interest 14.5 14.5 10.7 6.1 Net Worth 159.1 232.9 378.5 567.7
Other Income 16.6 15.3 14.5 14.5 Total Loans 160.9 114.1 64.1 38.1
EBDT 66.1 143.0 204.2 263.3 Minority Interest 0.0 0.0 0.0 0.0
Depreciation 7.3 7.5 10.1 11.1 Net Deferred Tax Assets -0.2 0.0 0.0 0.0
Exp (Gain)/ Loss 163.7 0.0 0.0 0.0 Total Liabilities 319.9 347.1 442.6 605.8
Fores Gain / (Loss) 21.0 19.8 0.0 0.0 Net Fixed Assets 29.0 37.4 32.3 26.2
PBT -83.9 155.3 194.1 252.2 CWIP 0.0 0.0 0.0 0.0
Tax 1.7 2.8 48.5 63.1 Goodwill on consolidation 28.7 28.7 28.7 28.7
PAT -85.6 152.5 145.6 189.2 Investments 0.1 3.0 3.0 3.0
Adj PAT 57.1 132.8 145.6 189.2 Inventories 209.1 196.2 248.9 323.5
Pref Div @1% 0.4 0.2 0.0 0.0 Sundry Debtors 35.6 54.3 94.5 116.5
PAT after Pref Div 56.7 132.5 145.6 189.2 Cash & Bank 45.9 72.1 99.8 187.4
Shares o/s (Cr.) 3.2 3.2 3.2 3.2 Loans & Advances 52.5 74.8 93.3 115.0
EPS -26.7 47.3 45.2 58.8 C A L&A 343.1 397.2 536.4 742.3
Adj EPS* 17.8 41.3 45.2 58.8 CL & P 80.9 119.2 157.8 194.4
Cash EPS -24.4 49.7 48.4 62.2 Working Capital 262.2 278.0 378.7 547.9
DPS (Rs.) 0.0 0.0 0.0 0.0 Total Assets 319.9 347.1 442.6 605.8
Quarterly (Rs. In Cr) Sep.13 Dec.13 Mar.14 Jun.14 Cash Flow FY13 FY14E FY15E FY16E
Revenue including OI 321.6 374.9 363.9 303.2 Operating
EBITDA 29.5 51.8 32.3 22.8 Profit Before Tax -83.9 155.3 194.1 252.2
Interest 3.9 4.1 3.0 2.5 Direct Taxes paid -1.6 -2.8 -48.5 -63.1
EBDT 25.6 47.7 29.3 20.3 Depreciation 7.3 7.5 10.1 11.1
Dep 1.7 1.8 2.5 2.0 Change in WC -19.5 -4.5 -72.9 -81.6
Other Inc. 0.0 0.0 0.0 0.0 Interest Expenses 12.4 14.5 10.7 6.1
Forex Gain/Loss 11.1 -3.6 1.5 3.5 Ot Op Activities 162.3 0.0 0.0 0.0
Exceptional 0.0 0.0 0.0 0.0 CF from Operation 77.0 170.1 93.4 124.8
PBT 35.0 42.2 28.3 21.9 Investment
Tax 2.1 6.8 -6.9 3.6 Capex -13.5 -16.0 -5.0 -5.0
PAT 32.9 35.4 35.2 18.3 Other Investment 13.8 -2.9 0.0 0.0
Adjusted EPS (Rs.) 13.7 9.9 11.4 6.8 Total Investment 0.3 -18.8 -5.0 -5.0
Operational Ratio FY13 FY14E FY15E FY16E Free Cash Flow 77.3 151.2 88.4 119.8
EBITDA margin (%) 7.2% 11.0% 12.4% 12.8% Financing
Adj.PAT margin (%) 6.4% 10.2% 9.0% 9.5% Equity raised/(repaid) 0.0 0.0 0.0 0.0
Adj.PAT Growth (%) -8.3% 132.5% 9.7% 29.9% Issuance of shares 1.0 0.0 0.0 0.0
Price Earnings (x) 48.1 20.6 18.8 14.5 Repayment of Red. PS 0.0 -44.0 0.0 0.0
Book Value (Rs.) 35.9 72.4 117.6 176.4 Debt raised/(repaid) -16.7 -46.8 -50.0 -26.0
ROCE (%) 19.2% 45.0% 51.9% 49.3% Dividend (incl. tax) paid 0.0 0.0 0.0 0.0
RONW (%) 26.7% 67.6% 47.6% 40.0% Interest Expenses -12.4 -14.5 -10.7 -6.1
Debt Equity Ratio 1.0 0.5 0.2 0.1 Deposits 0.0 0.0 0.0 0.0
Price / Book Value (x) 23.7 11.7 7.2 4.8 Foreign Currency Translation -21.9 -19.8 0.0 0.0
EV / Sales 3.0 2.1 1.6 1.3 CFF Financing Activities -50.1 -125.1 -60.7 -32.1
EV / EBIDTA 41.9 18.7 13.2 10.0 Net Cash Flow 27.2 26.2 27.7 87.6
Beginning Cash Flow 18.7 45.9 72.1 99.8
Closing Cash Balance 45.9 72.1 99.8 187.4
5 | P a g e
IInniittiiaattiinnggCCoovveerraaggee
Vaibhav Global Ltd. (VGL)
QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144
Disclaimer:
This Document has been prepared by Nirmal Bang Research (A Division of Nirmal Bang Securities PVT LTD). The information, analysis and
estimates contained herein are based on Nirmal Bang Research assessment and have been obtained from sources believed to be reliable. This
document is meant for the use of the intended recipient only. This document, at best, represents Nirmal Bang Research opinion and is meant for
general information only. Nirmal Bang Research, its directors, officers or employees shall not in anyway be responsible for the contents stated
herein. Nirmal Bang Research expressly disclaims any and all liabilities that may arise from information, errors or omissions in this connection. This
document is not to be considered as an offer to sell or a solicitation to buy any securities. Nirmal Bang Research, its affiliates and their employees
may from time to time hold positions in securities referred to herein. Nirmal Bang Research or its affiliates may from time to time solicit from or
perform investment banking or other services for any company mentioned in this document.
Nirmal Bang Research (Division of Nirmal Bang Securities Pvt. Ltd.)
B-2, 301/302, Marathon Innova,
Opp. Peninsula Corporate Park
Off. Ganpatrao Kadam Marg
Lower Parel (W), Mumbai-400013
Board No. : 91 22 3926 8000/8001
Fax. : 022 3926 8010

More Related Content

What's hot

Q1 2021 Investor Presentatio
 Q1 2021 Investor Presentatio Q1 2021 Investor Presentatio
Q1 2021 Investor Presentatio
NEXONIR
 
Ccall 3 q11_ing
Ccall 3 q11_ingCcall 3 q11_ing
Ccall 3 q11_ing
ItauRI
 
Lkq corporations fourth quarter and full year 2016 earnings call presentation
Lkq corporations fourth quarter and full year 2016 earnings call presentationLkq corporations fourth quarter and full year 2016 earnings call presentation
Lkq corporations fourth quarter and full year 2016 earnings call presentation
corporationlkq
 
Q2 2020 Investor Presentation
 Q2 2020 Investor Presentation Q2 2020 Investor Presentation
Q2 2020 Investor Presentation
NEXONIR
 
Ongc ru4 qfy2010-280510
Ongc ru4 qfy2010-280510Ongc ru4 qfy2010-280510
Ongc ru4 qfy2010-280510Angel Broking
 
Jagran prakashan ru2 qfy2011-291010
Jagran prakashan ru2 qfy2011-291010Jagran prakashan ru2 qfy2011-291010
Jagran prakashan ru2 qfy2011-291010Angel Broking
 
Financial Results for the 2nd Quarter of the Fiscal Year Ending March 2016
Financial Results for the 2nd Quarter of the Fiscal   Year Ending March 2016Financial Results for the 2nd Quarter of the Fiscal   Year Ending March 2016
Financial Results for the 2nd Quarter of the Fiscal Year Ending March 2016
KDDI
 
Grendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 EarningsGrendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 Earnings
Grendene
 
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
IndiaNotes.com
 
1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf
Hyundai Finance
 
1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf
Hyundai Finance
 
Lkq q2 2017 earnings call presentation
Lkq q2 2017 earnings call presentationLkq q2 2017 earnings call presentation
Lkq q2 2017 earnings call presentation
corporationlkq
 
Idea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIdea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buy
IndiaNotes.com
 
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
corporationlkq
 
Bank of india ru2 qfy2011-221010
Bank of india ru2 qfy2011-221010Bank of india ru2 qfy2011-221010
Bank of india ru2 qfy2011-221010Angel Broking
 
1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf
Hyundai Finance
 
Third Quarter 2017 Earnings Call Presentation
Third Quarter 2017 Earnings Call PresentationThird Quarter 2017 Earnings Call Presentation
Third Quarter 2017 Earnings Call Presentation
corporationlkq
 
Fiscal Year Ended March 2021 (FY2020)Financial Highlights
Fiscal Year Ended March 2021 (FY2020)Financial HighlightsFiscal Year Ended March 2021 (FY2020)Financial Highlights
Fiscal Year Ended March 2021 (FY2020)Financial Highlights
RicohLease
 
Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016
Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016
Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016
KDDI
 

What's hot (20)

Q1 2021 Investor Presentatio
 Q1 2021 Investor Presentatio Q1 2021 Investor Presentatio
Q1 2021 Investor Presentatio
 
Ccall 3 q11_ing
Ccall 3 q11_ingCcall 3 q11_ing
Ccall 3 q11_ing
 
Lkq corporations fourth quarter and full year 2016 earnings call presentation
Lkq corporations fourth quarter and full year 2016 earnings call presentationLkq corporations fourth quarter and full year 2016 earnings call presentation
Lkq corporations fourth quarter and full year 2016 earnings call presentation
 
Q2 2020 Investor Presentation
 Q2 2020 Investor Presentation Q2 2020 Investor Presentation
Q2 2020 Investor Presentation
 
Ongc ru4 qfy2010-280510
Ongc ru4 qfy2010-280510Ongc ru4 qfy2010-280510
Ongc ru4 qfy2010-280510
 
Jagran prakashan ru2 qfy2011-291010
Jagran prakashan ru2 qfy2011-291010Jagran prakashan ru2 qfy2011-291010
Jagran prakashan ru2 qfy2011-291010
 
Financial Results for the 2nd Quarter of the Fiscal Year Ending March 2016
Financial Results for the 2nd Quarter of the Fiscal   Year Ending March 2016Financial Results for the 2nd Quarter of the Fiscal   Year Ending March 2016
Financial Results for the 2nd Quarter of the Fiscal Year Ending March 2016
 
Grendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 EarningsGrendene - 1st Qquarter 2006 Earnings
Grendene - 1st Qquarter 2006 Earnings
 
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 Q3FY15 Recommendation: Maintain hold on Alembic Pharma Q3FY15 Recommendation: Maintain hold on Alembic Pharma
Q3FY15 Recommendation: Maintain hold on Alembic Pharma
 
1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf
 
1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf
 
Lkq q2 2017 earnings call presentation
Lkq q2 2017 earnings call presentationLkq q2 2017 earnings call presentation
Lkq q2 2017 earnings call presentation
 
Idea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buyIdea Cellular: Q1FY15 results above estimates, buy
Idea Cellular: Q1FY15 results above estimates, buy
 
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
Lkq corporations-fourth-quarter-and-full-year-2017-earnings-conference-call-p...
 
4Q10 analyst meeting
4Q10 analyst meeting4Q10 analyst meeting
4Q10 analyst meeting
 
Bank of india ru2 qfy2011-221010
Bank of india ru2 qfy2011-221010Bank of india ru2 qfy2011-221010
Bank of india ru2 qfy2011-221010
 
1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf1 q19 hcs_presentation_web_eng_190529.vf
1 q19 hcs_presentation_web_eng_190529.vf
 
Third Quarter 2017 Earnings Call Presentation
Third Quarter 2017 Earnings Call PresentationThird Quarter 2017 Earnings Call Presentation
Third Quarter 2017 Earnings Call Presentation
 
Fiscal Year Ended March 2021 (FY2020)Financial Highlights
Fiscal Year Ended March 2021 (FY2020)Financial HighlightsFiscal Year Ended March 2021 (FY2020)Financial Highlights
Fiscal Year Ended March 2021 (FY2020)Financial Highlights
 
Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016
Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016
Financial Results for the 3rd Quarter of the Fiscal Year Ending March 2016
 

Similar to Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold

Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangZydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangIndiaNotes.com
 
Vaibhav Global: Results in-line with expectation, hold - Nirmal Bang
Vaibhav Global: Results in-line with expectation, hold - Nirmal BangVaibhav Global: Results in-line with expectation, hold - Nirmal Bang
Vaibhav Global: Results in-line with expectation, hold - Nirmal BangIndiaNotes.com
 
Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165
IndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
IndiaNotes.com
 
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangIndiaNotes.com
 
Bayer india ru4qfy2010-020610
Bayer india ru4qfy2010-020610Bayer india ru4qfy2010-020610
Bayer india ru4qfy2010-020610Angel Broking
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
IndiaNotes.com
 
ING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutralING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutral
IndiaNotes.com
 
Dish TV: TRAI licence recos EBITDA positive but cash negative; Buy
Dish TV: TRAI licence recos EBITDA positive but cash negative; BuyDish TV: TRAI licence recos EBITDA positive but cash negative; Buy
Dish TV: TRAI licence recos EBITDA positive but cash negative; Buy
IndiaNotes.com
 
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 Zensar Technologies Q1FY15: Results in line with our expectations, buy Zensar Technologies Q1FY15: Results in line with our expectations, buy
Zensar Technologies Q1FY15: Results in line with our expectations, buy
IndiaNotes.com
 
Britannia Industries 1QFY15 results ahead of estimate; buy - Motilal Oswal
Britannia Industries 1QFY15 results ahead of estimate; buy - Motilal OswalBritannia Industries 1QFY15 results ahead of estimate; buy - Motilal Oswal
Britannia Industries 1QFY15 results ahead of estimate; buy - Motilal OswalIndiaNotes.com
 
Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15E
IndiaNotes.com
 
Zee 1QFY18
Zee 1QFY18Zee 1QFY18
Zee 1QFY18
Mohit Jn
 
Presentation Material for 3Q / Mar. 2020
Presentation Material for 3Q / Mar. 2020Presentation Material for 3Q / Mar. 2020
Presentation Material for 3Q / Mar. 2020
RicohLease
 
Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014
IndiaNotes.com
 
Bajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; holdBajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; hold
IndiaNotes.com
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18
Mohit Jn
 
Financial_Highlights_FY20214Q.pdf
Financial_Highlights_FY20214Q.pdfFinancial_Highlights_FY20214Q.pdf
Financial_Highlights_FY20214Q.pdf
RicohLease
 
20160502 olympus pres
20160502 olympus pres20160502 olympus pres
20160502 olympus pres
Travis Lundy
 
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal OswalSun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
IndiaNotes.com
 

Similar to Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold (20)

Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal BangZydus Wellness reports a subdued quarter, hold - Nirmal Bang
Zydus Wellness reports a subdued quarter, hold - Nirmal Bang
 
Vaibhav Global: Results in-line with expectation, hold - Nirmal Bang
Vaibhav Global: Results in-line with expectation, hold - Nirmal BangVaibhav Global: Results in-line with expectation, hold - Nirmal Bang
Vaibhav Global: Results in-line with expectation, hold - Nirmal Bang
 
Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165Jagran Prakashan Q2FY15: Buy for a target of Rs165
Jagran Prakashan Q2FY15: Buy for a target of Rs165
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal BangQ2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
Q2FY15: Hold Mahindra & Mahindra Financial Services - Nirmal Bang
 
Bayer india ru4qfy2010-020610
Bayer india ru4qfy2010-020610Bayer india ru4qfy2010-020610
Bayer india ru4qfy2010-020610
 
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQMahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
Mahindra Financial result update: 4QFY15 PAT up 7% YoY and 144% QoQ
 
ING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutralING Vyasa Bank Q2FY14 Result: Maintain neutral
ING Vyasa Bank Q2FY14 Result: Maintain neutral
 
Dish TV: TRAI licence recos EBITDA positive but cash negative; Buy
Dish TV: TRAI licence recos EBITDA positive but cash negative; BuyDish TV: TRAI licence recos EBITDA positive but cash negative; Buy
Dish TV: TRAI licence recos EBITDA positive but cash negative; Buy
 
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 Zensar Technologies Q1FY15: Results in line with our expectations, buy Zensar Technologies Q1FY15: Results in line with our expectations, buy
Zensar Technologies Q1FY15: Results in line with our expectations, buy
 
Britannia Industries 1QFY15 results ahead of estimate; buy - Motilal Oswal
Britannia Industries 1QFY15 results ahead of estimate; buy - Motilal OswalBritannia Industries 1QFY15 results ahead of estimate; buy - Motilal Oswal
Britannia Industries 1QFY15 results ahead of estimate; buy - Motilal Oswal
 
Cipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15ECipla Q2 disappoints, gearing up for strong H2FY15E
Cipla Q2 disappoints, gearing up for strong H2FY15E
 
Zee 1QFY18
Zee 1QFY18Zee 1QFY18
Zee 1QFY18
 
Presentation Material for 3Q / Mar. 2020
Presentation Material for 3Q / Mar. 2020Presentation Material for 3Q / Mar. 2020
Presentation Material for 3Q / Mar. 2020
 
Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014Motilal oswal dishtv_30oct_2014
Motilal oswal dishtv_30oct_2014
 
Bajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; holdBajaj Finance: Strong growth momentum; hold
Bajaj Finance: Strong growth momentum; hold
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18
 
Financial_Highlights_FY20214Q.pdf
Financial_Highlights_FY20214Q.pdfFinancial_Highlights_FY20214Q.pdf
Financial_Highlights_FY20214Q.pdf
 
20160502 olympus pres
20160502 olympus pres20160502 olympus pres
20160502 olympus pres
 
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal OswalSun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
Sun TV Q1FY15 adjusted PAT increases 5% YoY; buy - buy - Motilal Oswal
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
IndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
IndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
IndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
IndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
IndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
IndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
IndiaNotes.com
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
IndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
IndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
IndiaNotes.com
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
IndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
IndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
IndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 

Recently uploaded

when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.
DOT TECH
 
655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf
morearsh02
 
how to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchangehow to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchange
DOT TECH
 
how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.
DOT TECH
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
DOT TECH
 
how to sell pi coins effectively (from 50 - 100k pi)
how to sell pi coins effectively (from 50 - 100k  pi)how to sell pi coins effectively (from 50 - 100k  pi)
how to sell pi coins effectively (from 50 - 100k pi)
DOT TECH
 
how can I sell pi coins after successfully completing KYC
how can I sell pi coins after successfully completing KYChow can I sell pi coins after successfully completing KYC
how can I sell pi coins after successfully completing KYC
DOT TECH
 
how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.
DOT TECH
 
Introduction to Indian Financial System ()
Introduction to Indian Financial System ()Introduction to Indian Financial System ()
Introduction to Indian Financial System ()
Avanish Goel
 
Proposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in EthereumProposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in Ethereum
RasoulRamezanian1
 
Economics and Economic reasoning Chap. 1
Economics and Economic reasoning Chap. 1Economics and Economic reasoning Chap. 1
Economics and Economic reasoning Chap. 1
Fitri Safira
 
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
Quotidiano Piemontese
 
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdfWhich Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
Kezex (KZX)
 
The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...
Antonis Zairis
 
NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...
NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...
NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...
Amil Baba Dawood bangali
 
how to swap pi coins to foreign currency withdrawable.
how to swap pi coins to foreign currency withdrawable.how to swap pi coins to foreign currency withdrawable.
how to swap pi coins to foreign currency withdrawable.
DOT TECH
 
PF-Wagner's Theory of Public Expenditure.pptx
PF-Wagner's Theory of Public Expenditure.pptxPF-Wagner's Theory of Public Expenditure.pptx
PF-Wagner's Theory of Public Expenditure.pptx
GunjanSharma28848
 
US Economic Outlook - Being Decided - M Capital Group August 2021.pdf
US Economic Outlook - Being Decided - M Capital Group August 2021.pdfUS Economic Outlook - Being Decided - M Capital Group August 2021.pdf
US Economic Outlook - Being Decided - M Capital Group August 2021.pdf
pchutichetpong
 
USDA Loans in California: A Comprehensive Overview.pptx
USDA Loans in California: A Comprehensive Overview.pptxUSDA Loans in California: A Comprehensive Overview.pptx
USDA Loans in California: A Comprehensive Overview.pptx
marketing367770
 
Intro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptxIntro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptx
shetivia
 

Recently uploaded (20)

when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.when will pi network coin be available on crypto exchange.
when will pi network coin be available on crypto exchange.
 
655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf655264371-checkpoint-science-past-papers-april-2023.pdf
655264371-checkpoint-science-past-papers-april-2023.pdf
 
how to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchangehow to sell pi coins on Bitmart crypto exchange
how to sell pi coins on Bitmart crypto exchange
 
how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.how to sell pi coins in South Korea profitably.
how to sell pi coins in South Korea profitably.
 
What price will pi network be listed on exchanges
What price will pi network be listed on exchangesWhat price will pi network be listed on exchanges
What price will pi network be listed on exchanges
 
how to sell pi coins effectively (from 50 - 100k pi)
how to sell pi coins effectively (from 50 - 100k  pi)how to sell pi coins effectively (from 50 - 100k  pi)
how to sell pi coins effectively (from 50 - 100k pi)
 
how can I sell pi coins after successfully completing KYC
how can I sell pi coins after successfully completing KYChow can I sell pi coins after successfully completing KYC
how can I sell pi coins after successfully completing KYC
 
how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.how can i use my minded pi coins I need some funds.
how can i use my minded pi coins I need some funds.
 
Introduction to Indian Financial System ()
Introduction to Indian Financial System ()Introduction to Indian Financial System ()
Introduction to Indian Financial System ()
 
Proposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in EthereumProposer Builder Separation Problem in Ethereum
Proposer Builder Separation Problem in Ethereum
 
Economics and Economic reasoning Chap. 1
Economics and Economic reasoning Chap. 1Economics and Economic reasoning Chap. 1
Economics and Economic reasoning Chap. 1
 
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...Turin Startup Ecosystem 2024  - Ricerca sulle Startup e il Sistema dell'Innov...
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...
 
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdfWhich Crypto to Buy Today for Short-Term in May-June 2024.pdf
Which Crypto to Buy Today for Short-Term in May-June 2024.pdf
 
The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...The new type of smart, sustainable entrepreneurship and the next day | Europe...
The new type of smart, sustainable entrepreneurship and the next day | Europe...
 
NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...
NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...
NO1 Uk Divorce problem uk all amil baba in karachi,lahore,pakistan talaq ka m...
 
how to swap pi coins to foreign currency withdrawable.
how to swap pi coins to foreign currency withdrawable.how to swap pi coins to foreign currency withdrawable.
how to swap pi coins to foreign currency withdrawable.
 
PF-Wagner's Theory of Public Expenditure.pptx
PF-Wagner's Theory of Public Expenditure.pptxPF-Wagner's Theory of Public Expenditure.pptx
PF-Wagner's Theory of Public Expenditure.pptx
 
US Economic Outlook - Being Decided - M Capital Group August 2021.pdf
US Economic Outlook - Being Decided - M Capital Group August 2021.pdfUS Economic Outlook - Being Decided - M Capital Group August 2021.pdf
US Economic Outlook - Being Decided - M Capital Group August 2021.pdf
 
USDA Loans in California: A Comprehensive Overview.pptx
USDA Loans in California: A Comprehensive Overview.pptxUSDA Loans in California: A Comprehensive Overview.pptx
USDA Loans in California: A Comprehensive Overview.pptx
 
Intro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptxIntro_Economics_ GPresentation Week 4.pptx
Intro_Economics_ GPresentation Week 4.pptx
 

Vaibhav Global Q1FY15: Outlook continues to remain positive; Hold

  • 1. 1 | P a g e IInniittiiaattiinnggCCoovveerraaggee Vaibhav Global Ltd. (VGL) QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144 4 Recommendation HOLD Outlook continues to remain positive As expected, the company reported sales growth of 20.3% yoy to Rs 301 cr, on account of sluggish TV Sales, which posted volume growth of 3.3% (vs 24.5% in Q4FY14 and 25.1% in Q1FY14), was down because of (1) Change in call center from in-house to third party (2) Build up of inventory at studio – as indicated by the company before the start of the quarter (3) Installation of new software. On account of above factors, we believe Q1 is a temporary blip and expect the growth to be normalized from Q3 onwards (Q2 is seasonally weak quarter for the company). Web sales volume grew by 36% and we expect to remain strong for the rest for the year. EBITDA has declined 24.5% yoy to Rs 26.3 cr. Consequently margins have also come down to 8.7% as against 13.9% in Q1FY14. We continue to like asset light business model of VGL which can generate high ROCE and free cash. VGL has stabilized itself as a retailer of discount fashion accessories through TV channel in US and UK market with access to over 100 million households and also trying to monetize its TV channel through development of web sales. We expect VGL to report an EPS of Rs. 45.2 and Rs. 58.8 in FY15E and FY16E respectively. At CMP of Rs. 850, VGL is trading at a PE of 18.8x FY15E and 14.5x FY16E. On 16x FY16E earnings our target price comes to Rs. 925 per share. We maintain HOLD rating.  Increase in average selling price: VGL reported increase in average selling price both in TV sales and Web sales segment. This is testament to company’s growing acceptability in the targeted markets. Web sales average selling price is $14 as compared to $11 in Q1FY14 whereas TV sales average price is $25 as compared to $ 24 in Q1FY14.  Web Sales supported the sales growth: Web sales grew by 79% to Rs 59 cr, compensated the decline in TV sales were impacted on account of one-time factors. We expect the company to continue the growth momentum for Web sales and believe TV sales to come back on track from Q3 onwards.  EBITDA declined: VGL reported an EBITDA margin of 8.7% down from 13.9% in Q1FY14 due to additional one-time cost the company has incurred during the quarter. The fact can be validated by difference between the gross margins which 68.8% in Q1FY15 vs 70.5% in QFY14. We expect VGL to report 12.4% margins for FY15E as against 11.0% in FY14.  PAT down: PAT is partially down by lower EBITDA and partially by higher tax. PAT for Q1FY15 is Rs 21.8 cr, down 45.5% yoy. As VGL’s accumulated losses got over, it’s both units – US and India have started paying tax (India under MAT and US full tax) and expected to have average tax rate of 25% for FY15.  Strong Cash Flow: The Company is having strong cash flow and utilizing the same to repay its debt. It has repaid Rs 29 cr in Q1FY15 and likely to debt free by FY15. CMP Rs. 850 Target Price Rs. 925 Sector Retail Stock Details BSE Code 532156 NSE Code VAIBHAVGBL Bloomberg Code VGM IN Market Cap (Rs cr) 2,767 Free Float (%) 62.9% 52- wk HI/Lo (Rs) 910/160 Avg. volume BSE (Quarterly) 15,039 Face Value (Rs) 10.0 Dividend (FY 14) NIL Shares o/s (Crs) 3.2 Relative Performance 1Mth 3Mth 1Yr Vaibhav 6.9% 16.6% 422.9% Sensex 2.7% 16.4% 34.8% Shareholding Pattern 30 th June 14 Foreign Promoter Indian Promoters Holding 40.78 Institutional (Incl. FII) 15.87 Corporate Bodies 4.8 Public & others 38.55 Runjhun Jain – Senior Research Analyst +91-22 3926 8177 runjhun.jain@nirmalbang.com Year Net Sales (Rs. in cr) Growth % EBIDTA EBIDTAM (%) APAT PATM (%) AEPS (Rs.) P/E (x) EV/Sales (x) ROE FY13A 892.9 38.1% 63.9 7.2% 57.1 6.4% 17.8 48.1 3.0 26.7% FY14A 1298.3 45.4% 142.2 11.0% 132.8 10.2% 41.3 20.6 2.1 67.6% FY15E 1619.8 24.8% 200.4 12.4% 145.6 9.0% 45.2 18.8 1.6 47.6% FY16E 1996.5 23.3% 255.0 12.8% 189.2 9.5% 58.8 14.5 1.3 40.0%
  • 2. 2 | P a g e IInniittiiaattiinnggCCoovveerraaggee Vaibhav Global Ltd. (VGL) QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144 Q1FY15 Consolidated Result Analysis Rs. in crore Particulars Q1FY15 Q1FY14 YoY% Q4FY14 QoQ% Net Sales 301.4 250.6 20.3% 359.6 -16.2% Other Operating Income 1.8 2.5 -26.9% 4.2 -57.1% Total Income 303.2 253.1 19.8% 363.9 -16.7% Increase / Decrease in Stock -9.6 -16.3 28.0 Consumption of RM 51.8 53.1 -2.4% 56.9 -8.9% Purchase of traded goods 51.8 37.2 39.3% 48.7 6.3% Total Raw-material Cost 94.0 73.9 27.2% 133.5 -29.6% Gross Profit 207.4 176.7 17.4% 226.1 -8.3% Employees Cost 46.4 41.4 12.0% 59.5 -22.0% Other Expenditure 136.5 102.9 32.6% 137.0 -0.4% Total Expenditure 276.8 218.2 26.9% 330.0 -16.1% EBITDA 26.3 34.9 -24.5% 33.9 -22.2% Interest 2.5 3.5 -28.3% 3.0 -18.4% Other Income 0.0 0.0 0.0 EBDT 23.9 31.4 -24.1% 30.8 -22.6% Depreciation 2.0 1.4 36.5% 2.5 -21.8% Exchange Gain/Loss 3.5 10.8 1.5 Exceptional Items 0.0 0.0 0.0 PBT 25.4 40.8 -37.7% 29.8 -14.8% Tax 3.6 0.7 -6.9 Reported PAT 21.8 40.0 -45.5% 36.8 -40.6% EPS (Unit Curr.) 6.8 12.5 11.4 Equity 32.2 32.1 32.2 Face Value 10 10 10 BPS BPS Gross Margin (%) 68.8% 70.5% 120 62.9% -510 EBITDA (%) 8.7% 13.9% 740 9.4% -360 EBDT (%) 7.9% 12.5% 810 8.6% -330 PAT (%) 7.2% 16.0% 7150 10.2% 160
  • 3. 3 | P a g e IInniittiiaattiinnggCCoovveerraaggee Vaibhav Global Ltd. (VGL) QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144 Segmental Breakup: Source: Company & Nirmal Bang Research
  • 4. 4 | P a g e IInniittiiaattiinnggCCoovveerraaggee Vaibhav Global Ltd. (VGL) QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144 Consolidated Financials Profitability (Rs. In Cr) FY13 FY14E FY15E FY16E Balance Sheet FY13 FY14E FY15E FY16E Revenues - Net 892.9 1298.3 1619.8 1996.5 Issued Share Capital 32.1 32.2 32.2 32.2 % change 38.1% 45.4% 24.8% 23.3% Redeemable Pref Share 44.0 0.0 0.0 0.0 EBITDA 63.9 142.2 200.4 255.0 Total Shares 76.1 32.2 32.2 32.2 % change -13.6% 122.6% 40.9% 27.2% Reserves & Surplus 83.1 200.8 346.3 535.5 Interest 14.5 14.5 10.7 6.1 Net Worth 159.1 232.9 378.5 567.7 Other Income 16.6 15.3 14.5 14.5 Total Loans 160.9 114.1 64.1 38.1 EBDT 66.1 143.0 204.2 263.3 Minority Interest 0.0 0.0 0.0 0.0 Depreciation 7.3 7.5 10.1 11.1 Net Deferred Tax Assets -0.2 0.0 0.0 0.0 Exp (Gain)/ Loss 163.7 0.0 0.0 0.0 Total Liabilities 319.9 347.1 442.6 605.8 Fores Gain / (Loss) 21.0 19.8 0.0 0.0 Net Fixed Assets 29.0 37.4 32.3 26.2 PBT -83.9 155.3 194.1 252.2 CWIP 0.0 0.0 0.0 0.0 Tax 1.7 2.8 48.5 63.1 Goodwill on consolidation 28.7 28.7 28.7 28.7 PAT -85.6 152.5 145.6 189.2 Investments 0.1 3.0 3.0 3.0 Adj PAT 57.1 132.8 145.6 189.2 Inventories 209.1 196.2 248.9 323.5 Pref Div @1% 0.4 0.2 0.0 0.0 Sundry Debtors 35.6 54.3 94.5 116.5 PAT after Pref Div 56.7 132.5 145.6 189.2 Cash & Bank 45.9 72.1 99.8 187.4 Shares o/s (Cr.) 3.2 3.2 3.2 3.2 Loans & Advances 52.5 74.8 93.3 115.0 EPS -26.7 47.3 45.2 58.8 C A L&A 343.1 397.2 536.4 742.3 Adj EPS* 17.8 41.3 45.2 58.8 CL & P 80.9 119.2 157.8 194.4 Cash EPS -24.4 49.7 48.4 62.2 Working Capital 262.2 278.0 378.7 547.9 DPS (Rs.) 0.0 0.0 0.0 0.0 Total Assets 319.9 347.1 442.6 605.8 Quarterly (Rs. In Cr) Sep.13 Dec.13 Mar.14 Jun.14 Cash Flow FY13 FY14E FY15E FY16E Revenue including OI 321.6 374.9 363.9 303.2 Operating EBITDA 29.5 51.8 32.3 22.8 Profit Before Tax -83.9 155.3 194.1 252.2 Interest 3.9 4.1 3.0 2.5 Direct Taxes paid -1.6 -2.8 -48.5 -63.1 EBDT 25.6 47.7 29.3 20.3 Depreciation 7.3 7.5 10.1 11.1 Dep 1.7 1.8 2.5 2.0 Change in WC -19.5 -4.5 -72.9 -81.6 Other Inc. 0.0 0.0 0.0 0.0 Interest Expenses 12.4 14.5 10.7 6.1 Forex Gain/Loss 11.1 -3.6 1.5 3.5 Ot Op Activities 162.3 0.0 0.0 0.0 Exceptional 0.0 0.0 0.0 0.0 CF from Operation 77.0 170.1 93.4 124.8 PBT 35.0 42.2 28.3 21.9 Investment Tax 2.1 6.8 -6.9 3.6 Capex -13.5 -16.0 -5.0 -5.0 PAT 32.9 35.4 35.2 18.3 Other Investment 13.8 -2.9 0.0 0.0 Adjusted EPS (Rs.) 13.7 9.9 11.4 6.8 Total Investment 0.3 -18.8 -5.0 -5.0 Operational Ratio FY13 FY14E FY15E FY16E Free Cash Flow 77.3 151.2 88.4 119.8 EBITDA margin (%) 7.2% 11.0% 12.4% 12.8% Financing Adj.PAT margin (%) 6.4% 10.2% 9.0% 9.5% Equity raised/(repaid) 0.0 0.0 0.0 0.0 Adj.PAT Growth (%) -8.3% 132.5% 9.7% 29.9% Issuance of shares 1.0 0.0 0.0 0.0 Price Earnings (x) 48.1 20.6 18.8 14.5 Repayment of Red. PS 0.0 -44.0 0.0 0.0 Book Value (Rs.) 35.9 72.4 117.6 176.4 Debt raised/(repaid) -16.7 -46.8 -50.0 -26.0 ROCE (%) 19.2% 45.0% 51.9% 49.3% Dividend (incl. tax) paid 0.0 0.0 0.0 0.0 RONW (%) 26.7% 67.6% 47.6% 40.0% Interest Expenses -12.4 -14.5 -10.7 -6.1 Debt Equity Ratio 1.0 0.5 0.2 0.1 Deposits 0.0 0.0 0.0 0.0 Price / Book Value (x) 23.7 11.7 7.2 4.8 Foreign Currency Translation -21.9 -19.8 0.0 0.0 EV / Sales 3.0 2.1 1.6 1.3 CFF Financing Activities -50.1 -125.1 -60.7 -32.1 EV / EBIDTA 41.9 18.7 13.2 10.0 Net Cash Flow 27.2 26.2 27.7 87.6 Beginning Cash Flow 18.7 45.9 72.1 99.8 Closing Cash Balance 45.9 72.1 99.8 187.4
  • 5. 5 | P a g e IInniittiiaattiinnggCCoovveerraaggee Vaibhav Global Ltd. (VGL) QQ11FFYY1155RReessuullttUUppddaattee––11AAuugguusstt22001144 Disclaimer: This Document has been prepared by Nirmal Bang Research (A Division of Nirmal Bang Securities PVT LTD). The information, analysis and estimates contained herein are based on Nirmal Bang Research assessment and have been obtained from sources believed to be reliable. This document is meant for the use of the intended recipient only. This document, at best, represents Nirmal Bang Research opinion and is meant for general information only. Nirmal Bang Research, its directors, officers or employees shall not in anyway be responsible for the contents stated herein. Nirmal Bang Research expressly disclaims any and all liabilities that may arise from information, errors or omissions in this connection. This document is not to be considered as an offer to sell or a solicitation to buy any securities. Nirmal Bang Research, its affiliates and their employees may from time to time hold positions in securities referred to herein. Nirmal Bang Research or its affiliates may from time to time solicit from or perform investment banking or other services for any company mentioned in this document. Nirmal Bang Research (Division of Nirmal Bang Securities Pvt. Ltd.) B-2, 301/302, Marathon Innova, Opp. Peninsula Corporate Park Off. Ganpatrao Kadam Marg Lower Parel (W), Mumbai-400013 Board No. : 91 22 3926 8000/8001 Fax. : 022 3926 8010